Sorrento Therape Correlations
SRNE Stock | USD 0 0.0005 16.67% |
The current 90-days correlation between Sorrento Therape and Valens is -0.1 (i.e., Good diversification). The correlation of Sorrento Therape is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Sorrento Therape Correlation With Market
Good diversification
The correlation between Sorrento Therape and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sorrento Therape and DJI in the same portfolio, assuming nothing else is changed.
Sorrento |
The ability to find closely correlated positions to Sorrento Therape could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sorrento Therape when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sorrento Therape - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sorrento Therape to buy it.
Moving together with Sorrento OTC Stock
0.72 | EC | Ecopetrol SA ADR | PairCorr |
0.66 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.63 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Sorrento OTC Stock
0.72 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.72 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.7 | WMT | Walmart Aggressive Push | PairCorr |
0.68 | CSCO | Cisco Systems Aggressive Push | PairCorr |
0.66 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.65 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
0.61 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.6 | HPQ | HP Inc | PairCorr |
0.51 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.5 | VFS | VinFast Auto Earnings Call This Week | PairCorr |
0.49 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.49 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
0.49 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
0.4 | KB | KB Financial Group | PairCorr |
0.35 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sorrento OTC Stock performing well and Sorrento Therape OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sorrento Therape's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
EQIX | 0.82 | 0.20 | 0.09 | 20.19 | 0.76 | 1.90 | 6.14 | |||
IPXXU | 0.04 | (0.01) | 0.00 | 0.72 | 0.00 | 0.28 | 0.65 | |||
VLN | 2.75 | (0.14) | 0.00 | (0.29) | 0.00 | 6.59 | 17.48 | |||
FRHC | 1.38 | 0.32 | 0.13 | 0.93 | 1.41 | 2.66 | 9.39 | |||
MS | 1.29 | 0.21 | 0.25 | 0.22 | 0.87 | 3.08 | 13.93 | |||
NMR | 1.56 | (0.01) | 0.00 | 0.11 | 2.04 | 3.43 | 8.85 | |||
GFS | 2.20 | (0.35) | (0.04) | 0.00 | 2.84 | 4.02 | 18.30 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sorrento Therape without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
All Next | Launch Module |
Sorrento Therape Corporate Management
Elected by the shareholders, the Sorrento Therape's board of directors comprises two types of representatives: Sorrento Therape inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sorrento. The board's role is to monitor Sorrento Therape's management team and ensure that shareholders' interests are well served. Sorrento Therape's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sorrento Therape's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Brunswick | VP Affairs | Profile | |
Scott Schaus | Chief Officer | Profile | |
Xiao MD | Pres ACEA | Profile | |
Robert Allen | VP RD | Profile | |
Brian Cooley | Sr BU | Profile | |
Shawn Sahebi | VP Operations | Profile |